v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
REVENUES
Operating Expenses    
Compensation and related expenses 1,001,704 2,899,987
Professional Fees 1,533,507 1,262,860
General and administrative 247,306 275,923
Research and development 1,159,993 1,022,412
Total Operating Expenses 3,942,510 5,461,182
Loss from Operations (3,942,510) (5,461,182)
Other Income (Expense) from operations    
Financing costs including interest (52,688) (74,390)
Inducement interest (397,928)
Gain on conversion of convertible debt 54,281
Total Other Expenses, net (450,616) (20,109)
Loss from operations before income taxes (4,393,126) (5,481,291)
Income Taxes
NET LOSS (4,393,126) (5,481,291)
PREFERRED STOCK    
Series A convertible contractual dividends (27,998) (27,620)
Series B convertible contractual dividends (150,895) (151,310)
Deemed dividend warrant modification (283,685) (41,225)
Deemed dividends from Series A and B conversion price reduction (305,541) (373,435)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (5,161,245) $ (6,074,881)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC $ (1.69) $ (3.45)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS: DILUTED $ (1.69) $ (3.45)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC 3,046,052 1,762,160
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: DILUTED 3,046,052 1,762,160